18 Oct

Oxford Biomedica – Options Study


Oxford Biomedica is a pioneer in gene and cell therapy with over twenty years experience in lentiviral vector and cell therapy, research, development and production. It was the first organisation to use these treatments on humans.


HFL undertook an options study to potentially back up steam heating and clean water systems. Alternatives were produced along with fully costed proposals, PFDs and preliminary equipment data sheets.


oxford bio